There are numerous articles demonstrating that cereblon-based PROTACs can rapidly, potently and highly selectively degrade, both in vitro and in vivo, a huge number of different proteins associated with the development of various diseases, including cancer, neurodegenerative diseases, immune diseases, cardiovascular diseases and viral infections33,34. Here, CRBN is linked to cancer.